FEELING achy, feverish or wiped out? As ‘superflu’ surges across the country, it might be easy to assume you’ve caught the ...
While both drugs share the same active ingredient, their positioning, pricing, and regulatory pathways diverge sharply, ...
Wegovy® (semaglutide injection) granted conditional marketing authorization for the treatment of non-cirrhotic metabolic dysfunction-associated ...
Pharmacists are urging people using weight loss injections to be alert to signs of dehydration as flu cases rise, warning ...
Flu cases are soaring across Ireland, with hospital admissions under serious pressure, as the HSE warns there’s still no peak ...
Novo Nordisk has the potential to maintain more consistent revenue growth throughout next year. There is an indication that ...
In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...
Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is conducting a study titled WEgovy Real ...
GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback